182 related articles for article (PubMed ID: 20039992)
1. Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation.
Kwak JJ; Pak HN; Jang JK; Kim SK; Park JH; Choi JI; Hwang C; Kim YH
J Cardiovasc Electrophysiol; 2010 Jun; 21(6):620-5. PubMed ID: 20039992
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural anticoagulation for atrial fibrillation ablation.
Mortada ME; Chandrasekaran K; Nangia V; Dhala A; Blanck Z; Cooley R; Bhatia A; Gilbert C; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):362-6. PubMed ID: 18284509
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
6. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.
Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620
[TBL] [Abstract][Full Text] [Related]
7. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD
J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
10. Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.
Gautam S; John RM; Stevenson WG; Jain R; Epstein LM; Tedrow U; Koplan BA; McClennen S; Michaud GF
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):248-54. PubMed ID: 20812929
[TBL] [Abstract][Full Text] [Related]
11. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
12. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
[TBL] [Abstract][Full Text] [Related]
13. Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration.
Kuwahara T; Takahashi A; Takahashi Y; Kobori A; Miyazaki S; Takei A; Fujino T; Okubo K; Takagi K; Fujii A; Takigawa M; Watari Y; Hikita H; Sato A; Aonuma K
J Cardiovasc Electrophysiol; 2013 May; 24(5):510-5. PubMed ID: 23350877
[TBL] [Abstract][Full Text] [Related]
14. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
[TBL] [Abstract][Full Text] [Related]
15. Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.
Tapanainen JM; Braunschweig F; Schwieler J; Insulander P; Bastani H; Drca N; Kennebäck G; Sadigh B; Jensen-Urstad M
Scand Cardiovasc J; 2013 Apr; 47(2):109-13. PubMed ID: 23098247
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.
Wazni OM; Beheiry S; Fahmy T; Barrett C; Hao S; Patel D; Di Biase L; Martin DO; Kanj M; Arruda M; Cummings J; Schweikert R; Saliba W; Natale A
Circulation; 2007 Nov; 116(22):2531-4. PubMed ID: 17998456
[TBL] [Abstract][Full Text] [Related]
17. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly.
Zado E; Callans DJ; Riley M; Hutchinson M; Garcia F; Bala R; Lin D; Cooper J; Verdino R; Russo AM; Dixit S; Gerstenfeld E; Marchlinski FE
J Cardiovasc Electrophysiol; 2008 Jun; 19(6):621-6. PubMed ID: 18462325
[TBL] [Abstract][Full Text] [Related]
19. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.
Xing Y; Xu B; Xu C; Peng F; Yang B; Qiu Y; Sun Y; Wang S; Guo H
Ann Pharmacother; 2017 Sep; 51(9):735-742. PubMed ID: 28573932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
